drugset / Trial / NCT02609932

Effect of IFN-γ on Innate Immune Cells

NCT02609932

Phase 1 Completed 20 enrolled University of Colorado, Denver
NaSingle-groupOpen-labelBasic science

Summary

The investigators hypothesize that neutrophils and monocytes developed under the influence of Interferon- gamma-1b (IFN-γ-1b, Actimmune\*) in vivo will display enhanced function across a broad range of activities related in large part to the transcriptional activation effects of this cytokine. The investigators will evaluate the effects of IFN-γ in healthy human subjects in vivo on gene expression, biologic activity markers, and functional activity of myeloid cells in single dose studies and in steady state studies.

Timeline

Start
2016-07
Primary completion
2018-08
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Interferon gamma-1b Protein / enzyme biologic 10 ug/m2 Subcutaneous
Subject Interferon gamma-1b Protein / enzyme biologic 25 ug/m2 Subcutaneous
Subject Interferon gamma-1b Protein / enzyme biologic 50 ug/m2 Subcutaneous
Subject Interferon gamma-1b Protein / enzyme biologic 100 ug/m2 Subcutaneous